LUNCH WORKSHOP AT THE AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE (AAAS) ANNUAL MEETING
An educational lunch workshop, "Anti-interferon Beta Antibodies in MS Care: A Consensus," featuring world-renowned neurology experts who will explore the issue of neutralizing antibodies (NAbs). The discussion will focus on:
The advent of biologics (protein-based medications) has benefited countless patients with chronic diseases including cancer, anemia, diabetes, rheumatoid arthritis, psoriasis and multiple sclerosis.
However, there has been an unexpected consequence: the development of NAbs, in which the body perceives protein-based therapies to be foreign and mounts an immune response against them. As treatment with biologics increases, the hot debate continues about whether NAbs are just innocent immunological bystanders or a natural defense mechanism that diminishes the efficacy of biologic therapies. Professionals need expert synthesis and consensus.
This program will outline in workshop style how a consensus was developed by the CMSC, the leading professional association in multiple sclerosis care.
Frederick Munschauer, MD, Chair, Department of Neurology, SUNY at Buffalo School of Medicine and Chief, The Jacobs Neurological Institute, Buffalo General Hospital, Buffalo, New York; Secretary of the B